Gilder Gagnon Howe & Co Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Affirm
AFRM
|
+$241M |
| 2 |
Twilio
TWLO
|
+$60M |
| 3 |
XYZ
Block Inc
XYZ
|
+$50.5M |
| 4 |
BridgeBio Pharma
BBIO
|
+$50M |
| 5 |
SoFi Technologies
SOFI
|
+$45.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$398M |
| 2 |
Roku
ROKU
|
+$137M |
| 3 |
Match Group
MTCH
|
+$117M |
| 4 |
Goldman Sachs
GS
|
+$107M |
| 5 |
Enphase Energy
ENPH
|
+$96M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.28% |
| 2 | Healthcare | 21.97% |
| 3 | Consumer Discretionary | 18.52% |
| 4 | Communication Services | 12.03% |
| 5 | Industrials | 4.42% |
Similar funds
Gilder Gagnon Howe & Co's Q1 2021 Portfolio in Review
As of Q1 2021, Gilder Gagnon Howe & Co held 430 positions worth $18.6B, down 7.9% from $20.1B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Gilder Gagnon Howe & Co withdrew a net $881M in Q1 2021, closing 27 positions and reducing 203 holdings. Its most notable exit was Eidos Therapeutics, Inc. Common Stock, an estimated $43.8M position sold in full.
By sector, the portfolio is most concentrated in Technology at 26% of assets, down from 28% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Gilder Gagnon Howe & Co opened a new position in Affirm worth $175M.
- Gilder Gagnon Howe & Co's largest Q1 2021 buy was Affirm: 2,479,834 shares worth $175M.
- Gilder Gagnon Howe & Co added most to Twilio in Q1 2021, an estimated $60M increase.
- Gilder Gagnon Howe & Co's biggest Q1 2021 reduction was Tesla, cutting an estimated $398M.
- Gilder Gagnon Howe & Co fully exited Eidos Therapeutics, Inc. Common Stock in Q1 2021, selling an estimated $43.8M.
- Gilder Gagnon Howe & Co's ten largest holdings make up 26% of its $18.6B portfolio in Q1 2021.
- Gilder Gagnon Howe & Co opened 84 new positions and closed 27 in Q1 2021.
- Gilder Gagnon Howe & Co's portfolio value fell 7.9% quarter-over-quarter to $18.6B.
Based on Gilder Gagnon Howe & Co's 13F filing for Q1 2021, filed 17 May 2021.